Clinical commentary for dental practitioners

As clinicians, we spend a considerable portion of our working day managing the consequences of periodontal disease. We debride, we instruct, we refer — and we watch patients return, year after year, fighting the same battle against gingivitis and periodontitis. Against this backdrop, a growing body of patient inquiry has emerged around collagen supplementation. Patients are asking whether it helps their gums. It is a fair question, and the honest answer is: more than we might expect.

Collagen in the Periodontium: A Brief Anatomy Refresher

Before evaluating supplementation, it is worth reestablishing why collagen matters to the structures we treat. Enamel — the outermost layer of the tooth — contains no collagen whatsoever; it is composed almost entirely of hydroxyapatite crystals, which is why it cannot regenerate. However, as we move inward and outward from the enamel, collagen becomes foundational. Types I, II, and III collagen are present throughout the pulpal tissue, secreted by odontoblasts and fibroblasts within the dentinal tubules and pulpal layers. More clinically relevant for the purposes of this discussion is the role collagen plays in the periodontium itself — the gingival tissue, the periodontal ligament, and the alveolar bone that together support every tooth in the arch. This architecture is largely collagenous, and its integrity is precisely what periodontitis destroys.

What Happens to Collagen in Periodontal Disease

Periodontal pathogens — particularly gram-negative anaerobes such as Porphyromonas gingivalis — produce collagenases and proteases that degrade the collagen matrix of the gingival connective tissue. This degradation is not simply a structural inconvenience. As the collagen scaffold breaks down, the gingiva loses its firmness and adherence, pockets deepen, and the alveolar bone loses its collagen-rich organic matrix, leaving it structurally weakened. The clinical signs we observe — bleeding on probing, recession, and eventual tooth mobility — are, in large part, a visible record of collagen destruction. The question is whether exogenous collagen, delivered orally in peptide form, can offer any meaningful support to this process.

The Clinical Evidence for Collagen Peptide Supplementation

The research here is early but encouraging. A 90-day randomised study involving patients with mild-to-moderate gingivitis found that daily supplementation with specific collagen peptides produced a statistically significant reduction in bleeding on probing — one of our most reliable clinical markers of gingival inflammation. The supplemented group also showed improvements in other periodontal inflammation indicators compared to controls. Separately, trials examining bovine-derived collagen have demonstrated enhanced gingival integrity, including measurably thicker gum tissue around teeth and, in over half of cases studied, complete coverage of previously exposed roots. For patients presenting with gingival recession — a condition notoriously difficult to manage non-surgically — these findings merit attention.

The proposed mechanism is twofold. First, collagen peptides ingested orally are hydrolysed in the gastrointestinal tract into di- and tripeptides, which are absorbed and distributed systemically. These peptides appear to act as signalling molecules, stimulating fibroblasts to produce new collagen and other extracellular matrix components — essentially encouraging the body's own repair machinery. Second, collagen supplementation has established benefits for bone mineral density, which we can reasonably extrapolate, with appropriate caution, to the alveolar bone that supports the dentition. Dedicated research on the periodontium in this regard remains limited, largely due to the long bone turnover timeline, but the broader skeletal evidence is consistent.

What Supplements Cannot Do

It is important to be precise with patients about the scope of these benefits. Collagen supplementation does not regenerate lost bone, and it does not reverse established gingival recession. Active periodontal infection requires clinical intervention — scaling, root planing, and where indicated, surgical management. No supplement changes that. What supplementation may do is support the host tissue's resilience before disease establishes, and assist healing and inflammation control in patients already under periodontal management. It belongs in the supportive, not curative, category.

Practical Considerations for Practice

When patients ask about collagen supplementation — and they will — the conversation is worth having substantively. Type I collagen is the most relevant to dental and gingival structures; it is the dominant collagen type in both dentin and gingival connective tissue. Marine and bovine-sourced hydrolysed collagen peptides are the most bioavailable forms, and the products reaching the mainstream market have improved considerably in quality. Brands such as The Collagen Co USA represent the kind of consumer-facing supplement now widely available, and while clinical endorsement of specific brands is outside our remit, patients are purchasing these products regardless. Helping them select a quality Type I hydrolysed product, rather than an undifferentiated gelatin capsule, is useful guidance.

Vitamin C co-supplementation is worth recommending in the same breath. Collagen synthesis is entirely dependent on adequate ascorbic acid, and deficiency — even subclinical deficiency — impairs the hydroxylation of proline and lysine residues essential to collagen triple-helix formation. Patients eating processed diets with low vegetable intake are at real risk of impaired collagen production for this reason alone.

A Measured but Genuine Opportunity

The evidence base for collagen supplementation in oral health is not yet at the level that warrants formal clinical guidelines. The studies are relatively small, the follow-up periods short, and the mechanistic picture, while plausible, is not complete. That said, the signal is consistent. Gingival inflammation markers improve. Tissue integrity improves. The biological rationale is sound. For patients with chronic gingivitis, early periodontitis, or post-surgical healing requirements, recommending a quality hydrolysed collagen supplement alongside standard periodontal care is a low-risk, potentially meaningful adjunct — and one that patients are already seeking out on their own. Better they do so with clinical guidance than without it.

This article is intended as a clinical commentary for dental practitioners and does not constitute prescriptive advice. Patients should be directed to consult with their treating clinician before commencing any supplementation programme.